Targeting triple negative breast cancer cells using surface modified solid lipid nanoparticles of niclosamide

dc.contributor.guide	T K, Praveen
dc.coverage.spatial	Pharmacy
dc.creator.researcher	Sai Kiran, Pindiprolu Satya Sesha
dc.date.accessioned	2020-02-19T06:55:48Z
dc.date.available	2020-02-19T06:55:48Z
dc.date.awarded	16/10/2019
dc.date.completed	2019
dc.date.registered	2016
dc.description.abstract	available
dc.description.note	quotsummary p 74, References p 75-92quot
dc.format.accompanyingmaterial	CD
dc.format.dimensions	3
dc.format.extent	i-xv, 1-97 p
dc.identifier.uri	http://hdl.handle.net/10603/277609
dc.language	English
dc.publisher.institution	Colleges of Pharmacy
dc.publisher.place	Mysore
dc.publisher.university	JSS Academy of Higher Education and Research
dc.relation	206
dc.rights	university
dc.source.university	University
dc.subject.keyword	Clinical Pre Clinical and Health,Pharmacology and Toxicology,Pharmacology and Pharmacy
dc.subject.keyword	Triple negative breast cancer; Tumor relapse; Metastasis; STAT3; Niclosamide; Solid lipid nanoparticles; Phenyl boronic acid.
dc.title	Targeting triple negative breast cancer cells using surface modified solid lipid nanoparticles of niclosamide
dc.title.alternative
dc.type.degree	Ph.D.